ZandCellZandCell
  • HOME
  • About
    • About
    • News Releases
  • Programs
  • Science
  • Apply
  • Contact
  • Login

    Lost your password?

  • 0
    Cart
  1. Home
  2. B. C. girl with leukemia seeks Christmas stem cell donor – DigitalJournal.com
  3. NEWS

NEWS

CRISPR used to record a film in bacteria – BioNews

Continue reading

2017-07-17 Michael Zand NEWS

New diabetes treatment teaches rogue immune cells to behave … – Chicago Tribune

Chicago TribuneNew diabetes treatment teaches rogue immune cells to behave …Chicago TribuneA treatment targeting wayward immune cells in people with type 1 or type 2 diabetes may help even years later, a new study finds.Stem Cell Educator Therapy May… Continue reading

2017-07-17 Michael Zand NEWS

‘Incredibly Exciting’: CAR T Cells as ‘Living Drugs’ – Medscape

CRISPR used to record a film in bacteria
BioNews
Scientists have used the CRISPR/Cas system to encode a movie in the genomes of living bacteria. However, the researchers’ ultimate goal is not to record movies or to ‘put Wikipedia into bacteria’, said first author Dr Seth Shipman from Harvard …

and more »

Continue reading

2017-07-17 Michael Zand NEWS

Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Average Trading Volume – First News 24

Editas Medicine, Inc. (NASDAQ:EDIT) Experiences Lighter than Average Trading VolumeFirst News 24CRISPR uses a protein-ribonucleic acid (RNA) complex composed of an enzyme, including either Cas9 (CRISPR associated protein 9) or Cpf1 (CRISPR from Prevote… Continue reading

2017-07-17 Michael Zand NEWS

FDA gives preliminary approval for CAR T-cell therapy – fox2now.com

‘Incredibly Exciting’: CAR T Cells as ‘Living Drugs’
Medscape
“Incredibly exciting” is how experts are describing the new development with chimeric antigen receptor (CAR) T cells, as the first of these novel therapies approaches the market. After last week’s unanimous vote in favor of recommending approval by the …

Continue reading

2017-07-17 Michael Zand NEWS

CNIC scientists find the key to improved cancer immunotherapy – EurekAlert (press release)

EurekAlert (press release)CNIC scientists find the key to improved cancer immunotherapyEurekAlert (press release)The results show that generation of an optimal immune response to cancer requires cooperation between two types of memory T cell–one circu… Continue reading

2017-07-17 Michael Zand NEWS

FDA embraces the first US application for a gene therapy, offering an accelerated test case – Endpoints News


CBS New York

FDA gives preliminary approval for CAR T-cell therapy
fox2now.com
ST. LOUIS, Mo. _ A new treatment is on the horizon for people suffering from cancer, specifically Leukemia. The FDA has given its preliminary approval for CAR T-Cell Therapy. It’s based on a person’s own genes. Dr. Mark Fesler, Oncologist with SLUCare …
‘Astounding’ gene therapy cancer drug heading for FDA approvalWCVB Boston
T–cell cancer therapy holds promise, longer-term results awaitBusiness Insider
Novel Gene Therapy for Leukemia Clears FDA PanelScientific American
myfox8.com –Toronto Sun –Biotechin.Asia
all 57 news articles »
Continue reading

2017-07-17 Michael Zand NEWS

Bioengineered Arteries Grown from Stem Cells – Anti Aging News

Anti Aging NewsBioengineered Arteries Grown from Stem CellsAnti Aging NewsScientists for the first time have produced cells that grow into fully functional arteries and they are on their way to clinical applications. For years, stem cell biologists hav… Continue reading

2017-07-17 Michael Zand NEWS
  • 1
  • …
  • 1,487
  • 1,488
  • 1,489
  • 1,490
  • 1,491
  • …
  • 3,595
Recent Posts
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Шведская компания ZandCell поставит 160 млн доз вакцины от COVID-19 в несколько стран мира 2021-07-22
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
Blog Categories
  • Anti-aging
  • Business
  • Google News RSS feed URL deprecation
  • NEWS
  • News Releases
  • Stem Cell Therapy
  • Veterinary
About Us

ZandCell is a biotechnology company pioneering the advancements and therapeutic applications of Stem Cell Therapy. Our Technology is called “Regenerate”.

SiteLock
Contact Info
+1-702-425-9049
+46-736-779970
info@zandcell.com
Find us on map


Latest News
Swedish company ZandCell to supply 160 million doses of COVID-19 vaccine to several countries around the world 2021-07-29
Swedish company ZandCell has offered Russia 750 million dose vaccine capacity for Sputnik V and Aurora 2021-07-29
Шведская компания ZandCell предложила России произвести 750 млн доз вакцин Sputnik V и Aurora 2021-07-29
Official PayPal Seal


© 2024 ZandCell. All Rights Reserved.
  • About
  • Programs
  • Science
  • Privacy Policy
  • Contact
  • RSS
  • Send us email
  • Follow us on Twitter
  • Follow us on Facebook
  • Follow Us on Linkedin
  • Call us via Skype
  • Follow Us on Instagram
  • Subscribe our YouTube Channel
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.

Endpoints News

FDA embraces the first US application for a gene therapy, offering an accelerated test case
Endpoints News
If the approval does come through, Spark will be in the lead in establishing a reimbursement model for a gene therapy in a market dominated by multiple payers. UniQure tried and failed in Europe with Glybera and now GSK is following up making slow …
Spark Therapeutics’ Biologics License Application for Investigational Voretigene Neparvovec Accepted for Filing by FDAGlobeNewswire (press release)

all 10 news articles »